WENA anewmeds.com Total Business Assets
Anew Medical, Inc. (WENA) is developing an advanced gene therapy system based on the Klotho protein to combat ALS and Alzheimer's disease, leveraging patent protection and biotech partnerships. The market dynamics of total assets, reaching 30.77 as reflected in the price action, are driven by the use of automated molecular analysis to accelerate research. As the startup is currently building its brand, investments in the company remain high-risk and speculative in nature.
Analytical breakdowns and data insights for company Anew Medical, Inc. (WENA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Anew Medical, Inc.|WENA - Long-Term Debt to Equity|Current Liabilities to Capital anewmeds.com|WENA - Company Aggregate Debts|Debts to Book Capitalization Anew Medical, Inc.|WENA - Company Long-Term Debt|Company Short-Term Indebtedness Anew Medical|Immediate Liquidity anewmeds.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Anew Medical, Inc.
Optimizing the logistics of pharmaceutical substances for neurological drugs through a laboratory pool minimizes the operational risks of Anew Medical, Inc., while the level of consolidated assets, calculated reversely via ROA, reflects the total volume of resources formed through equity and debt, allowing the investor to identify hidden leverage behind the rising share price and objectively assess the stability of the business's asset base.
Main competitors
biogen.com (BIIB) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Precision Medicines Inc - Total Business Assets|Company Total Assets AVXL (Anavex Corp)|CeriBell EEG (CBLL) - Company Assets|PRTA: Cumulative Company Assets|Alector, Inc. (ALEC) - Cumulative Company Assets|ANNX (Annexon) - Cumulative Company Assets|Omeros - Aggregate Asset Value|Aggregate Company Assets Neurogene Corp|Cumulative Company Assets AC Immune Inc (ACIU)|Company Total Assets VYGR|NMRA - Company Assets|Company Total Assets SCLX (Scilex)|TVGN: Total Business Assets|Alpha Cognition Corp - Company Total Assets|Company Total Asset Base Cognition Therapeutics Inc. CGTX|IKT: Company Total Assets|Cumulative Company Assets cassavasciences.com|ASRT (Assertio Holdings) - Company Total Assets|Company Total Assets Coya|Aggregate Company Assets Vistagen Therapeutics (VTGN)|Aggregate Company Assets OVID (ovidrx.com)|Acumen Pharmaceuticals - Cumulative Company Assets|Aggregate Asset Value CRVO|Alterity Therapeutics Ltd - Company Total Assets|Company Total Asset Base Clene Inc. CLNN|pepgen.com (PEPG) - Aggregate Company Assets|Total Business Assets JUNS|RLMD (Relmada Therapeutics) - Company Total Assets|Cumulative Company Assets annovisbio.com (ANVS)|Cumulative Company Assets GRCE (Grace Therapeutics, Inc.)|Company Total Asset Base Firefly Neuroscience, Inc.|Klotho Neurosciences - Cumulative Company Assets|NRSN - Cumulative Company Assets|Reviva Pharmaceuticals - Company Total Assets|Company Assets MetaVia Inc|NeurAxis (NRXS) - Aggregate Company Assets|Total Business Assets HSDT|PASG (Passage Bio Inc.) - Company Total Assets|Company Total Assets Neuphoria|Aggregate Company Assets Minerva Neurosciences (NERV)|athira.com - Total Business Assets|Company Total Assets ADXN (Addex Therapeutics Ltd)|Alzamend Neuro Inc. (ALZN) - Company Assets|CYCN: Cumulative Company Assets|PTIX - Company Total Assets|pasitheaclinics.com (KTTA) - Aggregate Company Assets|Cortigent - Aggregate Asset Value|Aggregate Company Assets Avenue Therapeutics, Inc.|Company Assets Brainstorm Cell Therapeutics Inc. BCLI|Company Total Assets CARA|Company Total Assets Chromocell (CHRO)|Aggregate Company Assets Eliem Therapeutics Inc. ELYM|ITCI: Total Business Assets|Longboard Pharmaceuticals, Inc. - Company Total Assets|Company Assets Marinus Pharmaceuticals Inc|NKGN (NKGen) - Cumulative Company Assets|Cumulative Company Assets NeuroBo Pharma|Cumulative Company Assets SAGE|SNPX: Aggregate Asset Value|Aggregate Company Assets Trevena (TRVN)|Cumulative Company Assets vigilneuro.com VIGL|Company Total Assets CERE (Cerevel)